Skip to main content
Press release March 3, 2026

Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference

Enanta Pharmaceuticals Inc (ENTA)

WATERTOWN, Mass. --(BUSINESS WIRE)--Mar. 3, 2026-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that members of management will participate in a fireside
View original release